Kenai Therapeutics
Kenai Therapeutics focuses on developing therapies for neurodegenerative movement disorders.
Kenai Therapeutics operates in biotechnology, health care, medical, therapeutics based in Greater San Diego Area, West Coast, Western US, founded in 2022.
Kenai Therapeutics is positioned in biotechnology, health care, medical, therapeutics, a segment that rewards a clear, focused offering.
Its base of operations is Greater San Diego Area, West Coast, Western US.
Its current recorded stage is Series_A.
The company reports a headcount in the c_00001_00010 range.
Total disclosed funding stands at about $89M.
| Sector | Biotechnology, Health Care, Medical, Therapeutics |
|---|---|
| Headquarters | Greater San Diego Area, West Coast, Western US |
| Founded | 2022 |
| Employees | c_00001_00010 |
| Stage | series_a |
| Total funding | $89,000,000 |
Website: www.kenaitx.com
Browse related
Sign in to view the contact information we hold for Kenai Therapeutics.
Create a free account
Create a free account